Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 13Unknown 8Recruiting 8Active not recruiting 6Withdrawn 2Terminated 2Not yet recruiting 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 723Neoplasms 461Prostatic Neoplasms 398Carcinoma, Non-Small-Cell Lung 387Lung Neoplasms 310Leukemia, Myeloid, Acute 301Multiple Myeloma 270Colorectal Neoplasms 243Neoplasm Metastasis 240Pancreatic Neoplasms 238Leukemia 235Melanoma 217Lymphoma 213Precursor Cell Lymphoblastic Leukemia-Lymphoma 204Brain Neoplasms 195Recurrence 178Head and Neck Neoplasms 177Lymphoma, Non-Hodgkin 174Leukemia, Lymphocytic, Chronic, B-Cell 168Myelodysplastic Syndromes 167Ovarian Neoplasms 160Carcinoma, Hepatocellular 154Glioblastoma 149Carcinoma, Renal Cell 137Rectal Neoplasms 134Colonic Neoplasms 129Lymphoma, Large B-Cell, Diffuse 125Lymphoma, Follicular 125Hodgkin Disease 116Squamous Cell Carcinoma of Head and Neck 109

Interventions

Cetuximab 1Anesthesia, General 1Anesthesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × Pancreatic Adenocarcinoma × Clear all
NCT04992507 2025-07-10

Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study

Ohio State University Comprehensive Cancer Center

Phase 2 Terminated
8 enrolled 7 charts
Gastrointestinal

Pancreatic Adenocarcinoma

NCT02736578 2019-06-25

Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery

Stanford University

Phase 2 Terminated
8 enrolled 16 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡